RAPT Therapeutics, Inc. (NASDAQ: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Changes Management Comments

RAPT Therapeutics Appoints Rodney Young as Chief Financial OfficerDecember 4, 2019 8:00 AM Rapt Therapeutics (RAPT) PT Raised to $31 at UBSDecember 4, 2019 5:54 AM After-Hours Movers 12/03: (HQY) (GPRO) (MA) Higher; (RVNC) (RLMD) (RAPT) Lower (more...)December 3, 2019 6:02 PM Raptor Technology (RAPT) and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in AsiaDecember 3, 2019 4:14 PM